ID   ENOG_RAT                Reviewed;         434 AA.
AC   P07323;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   24-JUL-2024, entry version 201.
DE   RecName: Full=Gamma-enolase;
DE            EC=4.2.1.11;
DE   AltName: Full=2-phospho-D-glycerate hydro-lyase;
DE   AltName: Full=Enolase 2;
DE   AltName: Full=Neural enolase;
DE   AltName: Full=Neuron-specific enolase;
DE            Short=NSE;
GN   Name=Eno2; Synonyms=Eno-2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2865729; DOI=10.1073/pnas.82.21.7453;
RA   Sakimura K., Kushiya E., Obinata M., Odani S., Takahashi Y.;
RT   "Molecular cloning and the nucleotide sequence of cDNA for neuron-specific
RT   enolase messenger RNA of rat brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:7453-7457(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=3746946; DOI=10.1002/jnr.490160114;
RA   Forss-Petter S., Danielson P., Sutcliffe J.G.;
RT   "Neuron-specific enolase: complete structure of rat mRNA, multiple
RT   transcriptional start sites, and evidence suggesting post-transcriptional
RT   control.";
RL   J. Neurosci. Res. 16:141-156(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-28.
RX   PubMed=2450052; DOI=10.1016/0378-1119(87)90218-6;
RA   Sakimura K., Kushiya E., Takahashi Y., Suzuki Y.;
RT   "The structure and expression of neuron-specific enolase gene.";
RL   Gene 60:103-113(1987).
RN   [5]
RP   PROTEIN SEQUENCE OF 10-28; 32-50; 65-89; 106-120; 163-179; 184-193;
RP   240-262; 270-285; 307-326; 336-394 AND 407-422, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [6]
RP   POSSIBLE FUNCTION AS A NEUROTROPHIC FACTOR.
RX   PubMed=7753500; DOI=10.1016/0168-0102(94)00849-b;
RA   Hattori T., Takei N., Mizuno Y., Kato K., Kohsaka S.;
RT   "Neurotrophic and neuroprotective effects of neuron-specific enolase on
RT   cultured neurons from embryonic rat brain.";
RL   Neurosci. Res. 21:191-198(1995).
RN   [7]
RP   SUBCELLULAR LOCATION OF ALPHA/GAMMA HETERODIMER.
RX   PubMed=15041191; DOI=10.1016/j.neures.2003.12.006;
RA   Ueta H., Nagasawa H., Oyabu-Manabe Y., Toida K., Ishimura K., Hori H.;
RT   "Localization of enolase in synaptic plasma membrane as an alphagamma
RT   heterodimer in rat brain.";
RL   Neurosci. Res. 48:379-386(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Has neurotrophic and neuroprotective properties on a broad
CC       spectrum of central nervous system (CNS) neurons. Binds, in a calcium-
CC       dependent manner, to cultured neocortical neurons and promotes cell
CC       survival.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R)-2-phosphoglycerate = H2O + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:10164, ChEBI:CHEBI:15377, ChEBI:CHEBI:58289,
CC         ChEBI:CHEBI:58702; EC=4.2.1.11;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Mg(2+) is required for catalysis and for stabilizing the dimer.;
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 4/5.
CC   -!- SUBUNIT: Mammalian enolase is composed of 3 isozyme subunits, alpha,
CC       beta and gamma, which can form homodimers or heterodimers which are
CC       cell-type and development-specific.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}. Note=Can translocate to the plasma membrane in either
CC       the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: The alpha/alpha homodimer is expressed in embryo
CC       and in most adult tissues. The alpha/beta heterodimer and the beta/beta
CC       homodimer are found in striated muscle, and the alpha/gamma heterodimer
CC       and the gamma/gamma homodimer in neurons.
CC   -!- DEVELOPMENTAL STAGE: During ontogenesis, there is a transition from the
CC       alpha/alpha homodimer to the alpha/beta heterodimer in striated muscle
CC       cells, and to the alpha/gamma heterodimer in nerve cells. ENO2 levels
CC       in brain increase 10-30 days after birth. Levels continue to accumulate
CC       over the following few months (protein only).
CC   -!- SIMILARITY: Belongs to the enolase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M11931; AAA41119.1; -; mRNA.
DR   EMBL; M22770; AAA41725.1; -; Genomic_DNA.
DR   EMBL; AF019973; AAB72088.1; -; mRNA.
DR   EMBL; BC060310; AAH60310.1; -; mRNA.
DR   EMBL; X07727; CAA30556.1; -; Genomic_DNA.
DR   EMBL; X07728; CAA30556.1; JOINED; Genomic_DNA.
DR   EMBL; X07729; CAA30556.1; JOINED; Genomic_DNA.
DR   PIR; A24742; A24742.
DR   PIR; JC1039; JC1039.
DR   RefSeq; NP_647541.1; NM_139325.3.
DR   RefSeq; XP_003750705.1; XM_003750657.3.
DR   RefSeq; XP_006237392.1; XM_006237330.3.
DR   RefSeq; XP_006244698.1; XM_006244636.3.
DR   AlphaFoldDB; P07323; -.
DR   SMR; P07323; -.
DR   BioGRID; 246511; 2.
DR   IntAct; P07323; 1.
DR   MINT; P07323; -.
DR   STRING; 10116.ENSRNOP00000005535; -.
DR   GlyGen; P07323; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P07323; -.
DR   PhosphoSitePlus; P07323; -.
DR   SwissPalm; P07323; -.
DR   jPOST; P07323; -.
DR   PaxDb; 10116-ENSRNOP00000005535; -.
DR   Ensembl; ENSRNOT00000105821.1; ENSRNOP00000093168.1; ENSRNOG00000013141.7.
DR   Ensembl; ENSRNOT00055017400; ENSRNOP00055013998; ENSRNOG00055010283.
DR   Ensembl; ENSRNOT00060056278; ENSRNOP00060046483; ENSRNOG00060032488.
DR   Ensembl; ENSRNOT00065050628; ENSRNOP00065041602; ENSRNOG00065029257.
DR   GeneID; 24334; -.
DR   KEGG; rno:24334; -.
DR   UCSC; RGD:2554; rat.
DR   AGR; RGD:2554; -.
DR   CTD; 2026; -.
DR   RGD; 2554; Eno2.
DR   eggNOG; KOG2670; Eukaryota.
DR   GeneTree; ENSGT00950000182805; -.
DR   HOGENOM; CLU_031223_0_0_1; -.
DR   InParanoid; P07323; -.
DR   OrthoDB; 1093250at2759; -.
DR   PhylomeDB; P07323; -.
DR   TreeFam; TF300391; -.
DR   Reactome; R-RNO-70171; Glycolysis.
DR   Reactome; R-RNO-70263; Gluconeogenesis.
DR   UniPathway; UPA00109; UER00187.
DR   PRO; PR:P07323; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000013141; Expressed in cerebellum and 19 other cell types or tissues.
DR   GO; GO:0005938; C:cell cortex; IDA:CAFA.
DR   GO; GO:0009986; C:cell surface; IDA:CAFA.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030426; C:growth cone; IDA:CAFA.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:CAFA.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0043204; C:perikaryon; ISO:RGD.
DR   GO; GO:0000015; C:phosphopyruvate hydratase complex; IDA:CAFA.
DR   GO; GO:0001917; C:photoreceptor inner segment; ISO:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:CAFA.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004634; F:phosphopyruvate hydratase activity; IDA:CAFA.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0061621; P:canonical glycolysis; IDA:CAFA.
DR   GO; GO:0006094; P:gluconeogenesis; IDA:RGD.
DR   GO; GO:0006096; P:glycolytic process; IBA:GO_Central.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   CDD; cd03313; enolase; 1.
DR   Gene3D; 3.20.20.120; Enolase-like C-terminal domain; 1.
DR   Gene3D; 3.30.390.10; Enolase-like, N-terminal domain; 1.
DR   HAMAP; MF_00318; Enolase; 1.
DR   InterPro; IPR000941; Enolase.
DR   InterPro; IPR036849; Enolase-like_C_sf.
DR   InterPro; IPR029017; Enolase-like_N.
DR   InterPro; IPR020810; Enolase_C.
DR   InterPro; IPR020809; Enolase_CS.
DR   InterPro; IPR020811; Enolase_N.
DR   NCBIfam; TIGR01060; eno; 1.
DR   PANTHER; PTHR11902; ENOLASE; 1.
DR   PANTHER; PTHR11902:SF10; GAMMA-ENOLASE; 1.
DR   Pfam; PF00113; Enolase_C; 1.
DR   Pfam; PF03952; Enolase_N; 1.
DR   PIRSF; PIRSF001400; Enolase; 1.
DR   PRINTS; PR00148; ENOLASE.
DR   SFLD; SFLDS00001; Enolase; 1.
DR   SFLD; SFLDF00002; enolase; 1.
DR   SMART; SM01192; Enolase_C; 1.
DR   SMART; SM01193; Enolase_N; 1.
DR   SUPFAM; SSF51604; Enolase C-terminal domain-like; 1.
DR   SUPFAM; SSF54826; Enolase N-terminal domain-like; 1.
DR   PROSITE; PS00164; ENOLASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Cytoplasm; Direct protein sequencing;
KW   Glycolysis; Hydroxylation; Isopeptide bond; Lyase; Magnesium; Membrane;
KW   Metal-binding; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   CHAIN           2..434
FT                   /note="Gamma-enolase"
FT                   /id="PRO_0000134114"
FT   ACT_SITE        210
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   ACT_SITE        343
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         40
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         158
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         167
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         245
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         245
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         293
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         293
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         293
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         318
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         318
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         318
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         370..373
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         394
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         26
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P09104"
FT   MOD_RES         44
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P09104"
FT   MOD_RES         60
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         60
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         64
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         89
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         89
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         126
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         193
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         197
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17183"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17183"
FT   MOD_RES         202
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         228
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         228
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         233
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P09104"
FT   MOD_RES         233
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         256
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         287
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         335
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         343
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         406
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
SQ   SEQUENCE   434 AA;  47141 MW;  BAFFCE2F04BCCA45 CRC64;
     MSIQKIWARE ILDSRGNPTV EVDLHTAKGL FRAAVPSGAS TGIYEALELR DGDKQRYLGK
     GVLKAVDHIN STIAPALISS GLSVVEQEKL DNLMLELDGT ENKSKFGANA ILGVSLAVCK
     AGAAEKDLPL YRHIAQLAGN SDLILPVPAF NVINGGSHAG NKLAMQEFMI LPVGAESFRD
     AMRLGAEVYH TLKGVIKDKY GKDATNVGDE GGFAPNILEN SEALELVKEA IDKAGYTEKM
     VIGMDVAASE FYRDGKYDLD FKSPADPSRC ITGDQLGALY QDFVRNYPVV SIEDPFDQDD
     WAAWSKFTAN VGIQIVGDDL TVTNPKRIER AVEEKACNCL LLKVNQIGSV TEAIQACKLA
     QENGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL MRIEEELGEE
     ARFAGHNFRN PSVL
//
